Together, these results indicate that PROX1 plays an important role in the anti-proliferative effect of rapamycin and suggest that PROX1 protein level might be a useful marker for anti-cancer therapy of rapamycin in HCC. The gene discussed is PROX1; the disease is hepatocellular carcinoma.